EurekAlert! - Medicine and Health

Visit Our Homepage, RichardsChiropractic.com

The Latest Headlines on Spine~Mail News From Dr. Richards
Spine~Mail News Update ~
click to read

05/16/2008
Drug fends off kidney cancer progression
(Memorial Sloan-Kettering Cancer Center) New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.


05/16/2008
New method proposed for determining which patients should get treatment for colorectal cancer
(Mayo Clinic) A new study being presented at the American Society of Clinical Oncology meeting in Chicago (Abstract #4020), may change treatment practice in about 25 percent of patients with colon cancer, and is the basis for proposed changes to the way colorectal cancers will be staged.


05/16/2008
Bitter orange SRMs: Tools for product analysis/quality
(National Institute of Standards and Technology (NIST)) NIST has developed Standard Reference Materials for bitter orange, long used in folk medicine and now increasingly used in herbal weight-loss products. Researchers can use the new materials to develop and test analytical methods for compounds in bitter orange or as control materials for quality assurance.


05/16/2008
Fibroids common, but women have options
(American Roentgen Ray Society) Small fibroids located just beneath the lining of the uterus (submucosal) are more likely to move to the endometrial cavity after uterine artery embolization but usually don’t cause major complications, according to a new study.


05/16/2008
ACP says major system reforms needed to improve the state of primary care medicine in the US
(American College of Physicians) Declaring that "Primary care medicine is in a precipitous decline," David C. Dale, MD, FACP, president of the American College of Physicians (ACP), today joined with leading representatives of employers and consumers to issue a call for comprehensive reforms to attract, recruit and retain general internists and other primary care physicians. During a panel discussion of the state of primary care medicine in the US, Dr. Dale and other panelists spoke about the challenges facing primary care and potential solutions.


05/16/2008
New E-health recommendations from ACP aim to improve health care quality, safety, and access
(American College of Physicians) In a new position paper released today, the American College of Physicians says that collaboration among physicians, patients, technology developers, and policymakers must occur if E-health activities like electronic communication between physicians and their patients, remote monitoring of patients, personal and electronic health records, and patients seeking health information online are to transform health care in the US.


05/16/2008
Bone drug could help prevent the spread of breast cancer
(Washington University School of Medicine) Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to research at Washington University School of Medicine in St. Louis.


05/16/2008
Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials
(HCIL) Two new clinical trials presented by Calpis Co., Ltd. at the American Society of Hypertension Twenty-Third Annual Scientific Meeting and Exposition in New Orleans show that the milk-derived dietary supplement AmealPeptide reduces blood pressure in hypertensive patients.


05/16/2008
CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients
(JFK Communcations) New data show that CAPHOSOL, an advanced electrolyte solution, relieves painful oral mucositis and improves quality of life for cancer patients undergoing chemotherapy and radiation therapy. These data will be reported in two separate presentations, one today in an oral podium presentation and one tomorrow as a poster session, at the 33rd Annual Congress of the Oncology Nursing Society.


05/16/2008
Experts tackle shipment issues for beneficial radiation sources
(International Atomic Energy Agency) Delays and denials of shipments involving regulated radioactive materials used in medicine and industry are of growing concern to safety and industry experts. Meeting in Rome this week at an IAEA workshop, they agreed on an action plan for the Mediterranean region that seeks to ease hardships for hospitals, research centers and organizations that rely on timely delivery of beneficial radiation sources.


05/16/2008
Disabling mouse enzyme increases fertility
(Washington University School of Medicine) Changing the sugars attached to a hormone produced in the pituitary gland increased fertility levels in mice nearly 50 percent, a research group at Washington University School of Medicine in St. Louis has found. The change appears to alter a reproductive "thermostat," unveiling part of an intricate regulatory system that may one day be used to enhance human fertility.


05/16/2008
NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO
(NYU Langone Medical Center / New York University School of Medicine) The following news tips are based on abstracts or poster presentations at the annual meeting of the American Society of Clinical Oncology to be held in Chicago, Ill., May 30-June 3, 2008.


05/16/2008
Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
(University of Texas M. D. Anderson Cancer Center) Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center.


05/16/2008
Breaking news: Study revives Olympic prospects for amputee sprinter
(Rice University) Based on Rice and MIT findings, the Court of Arbitration for Sports in Lausanne, Switzerland, has ruled that Pistorius is eligible to participate in International Association of Athletics Federations sanctioned competitions. If he qualifies for the 2008 Beijing games, Pistorius would be the first disabled athlete ever to run against able-bodied athletes in an Olympic event.


05/16/2008
New study links fate of personal care products to environmental pollution and human health concerns
(Arizona State University) People's concern in maintaining germ-free homes has led to the widespread use of anti-bacterial soaps and cleaning agents. But the active ingredients of those antiseptic soaps have come under scrutiny due to environmental and human health concerns. Now, ASU Biodesign Institute researcher Rolf Halden and co-workers have shown that antimicrobial ingredients used a half a century ago persist today in estuarine sediments into which New York City and Baltimore have discharged their treated domestic wastewater.


05/16/2008
TetraQ recognized for toxicology services
(Research Australia) TetraQ, the integrated preclinical contract research provider based at The University of Queensland, has attained Good Laboratory Practice recognition for its toxicology services after satisfying rigorous internationally-benchmarked criteria.


05/16/2008
Research talent wins national Innovation in Nursing award
(Research Australia) Professor Claire Rickard, from Griffith's School of Nursing and Midwifery, has won the Innovation in Nursing category of the HESTA Australian Nursing Awards.


05/16/2008
New drug combination brings 1-2 punch against acute leukemia
(University of Texas M. D. Anderson Cancer Center) Researchers at the University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation.


05/16/2008
Novel enzyme inhibitor paves way for new cancer drug
(The Wistar Institute) Wistar Institute scientists have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development. Based on studies in human melanoma cells, the research paves the way for developing new ways to treat cancer by dampening overactive enzyme activity that leads to uncontrolled tumor growth. The study shows how small-molecule inhibitors can be designed to target a family of signaling proteins, called phosphatidyl-inositol-3-kinases, or PI3Ks.


05/16/2008
Researchers expand natural killer cells in cord blood to fight leukemia
(University of Texas M. D. Anderson Cancer Center) Researchers from The University of Texas M. D. Anderson Cancer Center have found a therapy that effectively kills human leukemia cells in mice using natural killer cells from umbilical cord blood.


05/16/2008
Latest research on GI health presented at DDW 2008
(American Gastroenterological Association) Highlights of new studies include colonoscopies, pancreatic cancer, liver disease, disparities, celiac disease, NSAIDS and imaging.


05/16/2008
Scientists on trail of way to predict NF1 tumor growth and associated malignant tumors
(Cincinnati Children's Hospital Medical Center) Researchers at Cincinnati Children's Hospital Medical Center have identified proteins that could be biological markers of non-cancerous nerve tumors called Neurofibromatosis 1, which can change to a highly aggressive cancer called malignant peripheral nerve sheath tumors. This new finding could help resolve a current lack of reliable ways to diagnose NF1 and MPNST in patients, according to a study presented at the annual meeting of the American Society of Pediatric Hematology/Oncology.


05/16/2008
Separation from mom, dad linked with learning trouble in kids
(University of Rochester Medical Center) In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsacks for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties.


05/15/2008
Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
(Mayo Clinic) Researchers in the North Central Cancer Treatment Group have shown that patients who receive intravenous calcium and magnesium before and after the chemotherapy drug oxaliplatin for the treatment of advanced colon cancer experience a significantly reduced incidence and severity of neurological side effects.


05/15/2008
Adding epratuzumab to standard therapy
(Mayo Clinic) Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group.